# Eli Lilly's Biotech Investments: 55 Startups in Its Portfolio (2026) > The 55 Biotech startups Eli Lilly has backed, by stage: $6.7B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/eli-lilly-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 15 - [Cabaletta Bio](https://millionrounds.com/company/cabaletta-bio) - [Vanqua Bio](https://millionrounds.com/company/vanqua-bio) - [Syndeio Biosciences](https://millionrounds.com/company/syndeio-biosciences) - [ProQR Therapeutics](https://millionrounds.com/company/proqr-therapeutics) - [HAYA Therapeutics](https://millionrounds.com/company/haya-therapeutics) - [Centrexion Therapeutics](https://millionrounds.com/company/centrexion-therapeutics) - [LTZ Therapeutics](https://millionrounds.com/company/ltz-therapeutics) - [ABL Bio](https://millionrounds.com/company/abl-bio) - [*RT* Rodeo Therapeutics](https://millionrounds.com/company/rodeo-therapeutics) - [Sunbird Bio](https://millionrounds.com/company/sunbird-bio) - [QurCan Therapeutics Inc.](https://millionrounds.com/company/qurcan-therapeutics-inc) - [Entrega](https://millionrounds.com/company/entrega) - [Blacksmith Medicines](https://millionrounds.com/company/blacksmith-medicines) - [Laverock Therapeutics](https://millionrounds.com/company/laverock-therapeutics) - [Remedium Bio](https://millionrounds.com/company/remedium-bio) ## Series A 15 - [AbCellera](https://millionrounds.com/company/abcellera) - [Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics) - [Myricx Bio](https://millionrounds.com/company/myricx-bio) - [Firefly Bio](https://millionrounds.com/company/firefly-bio) - [Stylus Medicine](https://millionrounds.com/company/stylus-medicine) - [Faze Medicines](https://millionrounds.com/company/faze-medicines) - [Dualitas Therapeutics](https://millionrounds.com/company/dualitas-therapeutics) - [Solu Therapeutics](https://millionrounds.com/company/solu-therapeutics) - [DiogenX](https://millionrounds.com/company/diogenx) - [GenEdit](https://millionrounds.com/company/genedit) - [*MN* Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience) - [Volastra Therapeutics](https://millionrounds.com/company/volastra-therapeutics) - [Fountain Therapeutics](https://millionrounds.com/company/fountain-therapeutics) - [Caldan Therapeutics](https://millionrounds.com/company/caldan-therapeutics) - [*A* ApoGen](https://millionrounds.com/company/apogen) ## Series B 15 - [Terns Pharmaceuticals](https://millionrounds.com/company/terns-pharmaceuticals) - [T-Therapeutics](https://millionrounds.com/company/t-therapeutics) - [Mariana Oncology](https://millionrounds.com/company/mariana-oncology) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [Aktis Oncology](https://millionrounds.com/company/aktis-oncology) - [SonoThera](https://millionrounds.com/company/sonothera) - [*DP* DTx Pharma](https://millionrounds.com/company/dtx-pharma) - [Cedilla Therapeutics](https://millionrounds.com/company/cedilla-therapeutics) - [Gate Bioscience](https://millionrounds.com/company/gate-bioscience) - [Arkuda Therapeutics](https://millionrounds.com/company/arkuda-therapeutics) - [BreezeBio](https://millionrounds.com/company/breezebio) - [AltPep](https://millionrounds.com/company/altpep) - [NextCure](https://millionrounds.com/company/nextcure) - [Incyclix Bio](https://millionrounds.com/company/incyclix-bio) - [AMPRION](https://millionrounds.com/company/amprion) ## Series C and later 8 - [Avidity Biosciences](https://millionrounds.com/company/avidity-biosciences) - [AdvanCell](https://millionrounds.com/company/advancell) - [*IM* Insilico Medicine](https://millionrounds.com/company/insilico-medicine) - [Beta Bionics](https://millionrounds.com/company/beta-bionics) - [Circle Pharma](https://millionrounds.com/company/circle-pharma) - [Lycia Therapeutics](https://millionrounds.com/company/lycia-therapeutics) - [*PS* Perlegen Sciences](https://millionrounds.com/company/perlegen-sciences) - [Affinia Therapeutics](https://millionrounds.com/company/affinia-therapeutics) ## Pre-seed and seed 2 - [Amber Bio](https://millionrounds.com/company/amber-bio) - [NanoSyrinx](https://millionrounds.com/company/nanosyrinx) ## Segment by segment ### Stage not reported 15 startups · $699M raised - [**Cabaletta Bio**](https://millionrounds.com/company/cabaletta-bio) Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases. United States $200M - [**Vanqua Bio**](https://millionrounds.com/company/vanqua-bio) Vanqua Bio is a biopharmaceutical company based in Chicago, founded in 2019. United States $130M - [**Syndeio Biosciences**](https://millionrounds.com/company/syndeio-biosciences) Syndeio Biosciences (from the Ancient Greek word "to connect") is a clinical-stage biotechnology company developing therapies to r United States $90M - [**ProQR Therapeutics**](https://millionrounds.com/company/proqr-therapeutics) Changing lives is what drives us at ProQR Therapeutics. Netherlands $68M - [**HAYA Therapeutics**](https://millionrounds.com/company/haya-therapeutics) HAYA Therapeutics, SA is a precision medicine and biotechnology company focused on developing innovative genomic medicines. Switzerland $67M - [**Centrexion Therapeutics**](https://millionrounds.com/company/centrexion-therapeutics) Centrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain. - $41M - [**LTZ Therapeutics**](https://millionrounds.com/company/ltz-therapeutics) LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. United States $38M - [**ABL Bio**](https://millionrounds.com/company/abl-bio) ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases. South Korea $18M ### Series A 15 startups · $1.4B raised - [**AbCellera**](https://millionrounds.com/company/abcellera) AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes. Canada $526M - [**Verve Therapeutics**](https://millionrounds.com/company/verve-therapeutics) Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease. United States $202M - [**Myricx Bio**](https://millionrounds.com/company/myricx-bio) Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer. United Kingdom $115M - [**Firefly Bio**](https://millionrounds.com/company/firefly-bio) Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. United States $94M - [**Stylus Medicine**](https://millionrounds.com/company/stylus-medicine) Stylus Medicine is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative in vivo genetic medicines. United States $85M - [**Faze Medicines**](https://millionrounds.com/company/faze-medicines) Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $81M - [**Dualitas Therapeutics**](https://millionrounds.com/company/dualitas-therapeutics) Dualitas Therapeutics is a biotechnology company based in South San Francisco, CA, founded in 2023. United States $65M - [**Solu Therapeutics**](https://millionrounds.com/company/solu-therapeutics) Solu Therapeutics is a Boston-based clinical-stage biotechnology company focused on developing precision medicines to target and e United States $41M ### Series B 15 startups · $2.1B raised - [**Terns Pharmaceuticals**](https://millionrounds.com/company/terns-pharmaceuticals) Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden. United States $730M - [**T-Therapeutics**](https://millionrounds.com/company/t-therapeutics) T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. United Kingdom $279M - [**Mariana Oncology**](https://millionrounds.com/company/mariana-oncology) Mariana Oncology is a biotechnology research industry. United States $175M - [*CT* **Capstan Therapeutics**](https://millionrounds.com/company/capstan-therapeutics) Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases. United States $175M - [**Aktis Oncology**](https://millionrounds.com/company/aktis-oncology) Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals. United States $175M - [**SonoThera**](https://millionrounds.com/company/sonothera) SonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies. United States $125M - [*DP* **DTx Pharma**](https://millionrounds.com/company/dtx-pharma) DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease. - $100M - [**Cedilla Therapeutics**](https://millionrounds.com/company/cedilla-therapeutics) Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases. United States $81M ### Series C and later 8 startups · $2.4B raised - [**Avidity Biosciences**](https://millionrounds.com/company/avidity-biosciences) Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector. United States $790M - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [*IM* **Insilico Medicine**](https://millionrounds.com/company/insilico-medicine) Hong Kong SAR China $392M - [**Beta Bionics**](https://millionrounds.com/company/beta-bionics) Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. United States $296M - [**Circle Pharma**](https://millionrounds.com/company/circle-pharma) Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides. United States $187M - [**Lycia Therapeutics**](https://millionrounds.com/company/lycia-therapeutics) Lycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California. United States $182M - [*PS* **Perlegen Sciences**](https://millionrounds.com/company/perlegen-sciences) Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes. United States $104M - [**Affinia Therapeutics**](https://millionrounds.com/company/affinia-therapeutics) Affinia Therapeutics is a preclinical-stage biotechnology company based in Waltham, Massachusetts, founded in 2019. United States $40M ### Pre-seed and seed 2 startups · $52M raised - [**Amber Bio**](https://millionrounds.com/company/amber-bio) Amber Bio is a biotechnology company focused on advancing genetic medicine through innovative RNA-based therapeutic platforms. United States $26M - [**NanoSyrinx**](https://millionrounds.com/company/nanosyrinx) NanoSyrinx is a UK-based synthetic biology company focused on developing a novel drug delivery platform called Nanosyringes. United Kingdom $26M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Eli Lilly as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Eli Lilly's AI portfolio** 13 startups · $1.4B](https://millionrounds.com/portfolio-maps/eli-lilly-ai-portfolio)[Portfolio map **Eli Lilly portfolio map** 86 startups · $12B](https://millionrounds.com/portfolio-maps/eli-lilly-portfolio-map)[Co-investors **Who invests with Eli Lilly** 69 co-investors](https://millionrounds.com/portfolio-maps/eli-lilly-co-investors)[Sector portfolio **Coinbase Ventures' Web3 & Crypto portfolio** 168 startups · $5.7B](https://millionrounds.com/portfolio-maps/coinbase-web3-crypto-portfolio)[Sector portfolio **Salesforce Ventures' AI portfolio** 115 startups · $181B](https://millionrounds.com/portfolio-maps/salesforce-ventures-ai-portfolio)[Sector portfolio **Google Ventures' AI portfolio** 81 startups · $16B](https://millionrounds.com/portfolio-maps/gv-ai-portfolio) ## Raising from investors like Eli Lilly? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)